The Effects of Magnesium – Melatonin - Vit B Complex Supplementation in Treatment of Insomnia

  • Gorica Djokic Clinic for Mental Disorders “Dr. Laza Lazarevic”, Belgrade, Serbia
  • Petar Vojvodic Clinic for Psychiatric Disorders “Dr. Laza Lazarevic”, Belgrade, Serbia
  • Davor Korcok Abela Pharm, Belgrade, Serbia
  • Anita Agic Abela Pharm, Belgrade, Serbia
  • Anica Rankovic Clinic for Mental Disorders “Dr. Laza Lazarevic”, Belgrade, Serbia
  • Vladan Djordjevic Clinic for Mental Disorders “Dr. Laza Lazarevic”, Belgrade, Serbia
  • Aleksandra Vojvodic Department of Dermatology and Venereology, Military Medical Academy, Belgrade, Serbia
  • Tatjana Vlaskovic-Jovicevic Clinic for Mental Disorders “Dr. Laza Lazarevic”, Belgrade, Serbia
  • Zorica Peric-Hajzler Military Medical Academy, Belgrade, Serbia
  • Jovana Vojvodic Clinic for Mental Disorders “Dr. Laza Lazarevic”, Belgrade, Serbia
  • Dusica Matovic Military Medical Academy, Belgrade, Serbia
  • Goran Sijan Clinic for Plastic Surgery and Burns, Military Medical Academy, Belgrade, Serbia
  • Uwe Wollina Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Dresden, Germany
  • Michael Tirant G. Marconi University, Rome, Italy
  • Van Thuong Nguyen Vietnam National Hospital of Dermatology and Venereology, Hanoi, Vietnam
  • Massimo Fioranelli Department of Nuclear Physics, sub-nuclear and radiation, G. Marconi University, Rome, Italy
  • Torello Lotti University of Rome G. Marconi, Rome, Italia
Keywords: insomnia, magnesium, melatonin, Athens insomnia scale, supplement

Abstract

Insomnia means difficulty in falling asleep and/or stays asleep. Insomnia commonly leads to daytime sleepiness, lethargy, and a general feeling of being unwell. The most common treatment of insomnia includes GABAA receptor positive allosteric modulators or Melatonin agonists. Our study aimed to evaluate the efficacy of Magnesium- melatonin-vitamin B complex supplement in the treatment of insomnia. The study included 60 patients diagnosed with insomnia. The patients were randomly divided into study group (N = 30), and control group (N = 30), and study group was treated with Magnesium-melatonin-vitamin B complex (one dose contains 175 mg liposomal magnesium oxide, 10 mg Vit B6, 16 μg vit B12, melatonin 1 mg, Extrafolate-S 600 μg) once a day 1 hour before sleep, during the 3 months. The severity of insomnia symptoms was measured by self-reported Athens insomnia scale (AIS), with a cut-off score by Soldatos (AIS score ≥ 6). Mean AIS score at zero points was 14,93 ± 3,778 in the study group and 14,37 ± 4,081 in the control group (p = 0,476), indicating the compatibility of the groups, and both scores correspond to mild to moderate insomnia. Mean AIS score after 3 months of the Magnesium- melatonin- vitamin B complex supplementation was 10,50 ± 4,21 corresponding to mild insomnia, while median AIS score in the control group was 15,13 ± 3,76 which is referred to moderate insomnia, and difference among groups was significant (p = 0,000). Our founding’s indicating that 3 months of the Magnesium- melatonin-vitamin B complex supplementation has a beneficial effect in the treatment of insomnia regardless of cause.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

Author Biography

Torello Lotti, University of Rome G. Marconi, Rome, Italia

Prof. Lotti is Full Professor of the Dermatology and Venereology at University of Studies Guglielmo Marconi, Rome, Italy. He is Honorary Professor of Dermatology - China Medical University Shenyang (2011), Lecturer at the New York Academy of Sciences "Howard Fox Memorial Lecture" (14 March 2012 - New York, NY – USA), and Chair, Executive Scientific Committee Vitiligo Research Foundation, New York , NY , USA. He is President of the World Health Academy, Dermatology since 2013. He has been Full Professor of the Dermatology and Venereology Division at University of Florence School of Medicine, Florence, Italy, from 2006 to 2010. He is Visiting Professor in six International Universities worldwide, and Key Note Lecturer in several international dermatology Societies. His activities in serving Dermatology have been numerous: President of the Italian Society of Dermatology and Venereology (SIDeMaST , 2009-2010) and President of the International Society of Dermatology ( ISD, 2009-2010), President of the European Society for Cosmetic and Aesthetic Dermatology (2003-2004), Editor in Chief of the Journal of the European Academy of Dermatology and Venereology (1992-2002) , Editor "Therapeutic Hotline"- Dermatologic Therapy (2007-)and served as Editor in Chief of the Giornale Italiano di Dermatologia in the period of presidency of the Societa' Italiana di Dermatologia (2009-2010). He has been President of numerous international congresses and is currently Editor in Chief of the Giornale Italiano di Dermatologia e Venereologia ( 2010-2020 ). He is Ordinary Member of the main Scientific Societies worldwide (EADV, SIDEV , ESDR , ISD, AAD, SID) and Honorary Member of several Scientific Societies of the Dermatology field. Moreover, he is a Scientific reviewer of ten sectorial journals, among which are the British Journal of Dermatology, Journal of Investigative Dermatology, Journal of the American Academy of Dermatology , Dermatologic Therapy. He has authored 1054 scientific publications (393 peer reviewed articles, 288 books chapters e 365 abstracts). For more information, see www.torellolotti.it

References

Healthline Editorial Team, Lamoreux K. Everything You Need to Know About Insomnia, 2018. Available from: https://www.healthline.com/health/insomnia. Last accessed 26 Nov 2018.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA: American Psychiatric Association Publishing, 2013. https://doi.org/10.1176/appi.books.9780890425596

Zohar J, Stahl S, Moller HJ, Blier P, Kupfer D, Yamawaki S, Ucheida S, Draggo F, Goodwin G, Nutt D. Neuroscience based Nomenclature- the second edition, 2018. Available from: http://www.nbn2.com/ (Last accessed 27 Nov 2018).

Breus M. Understanding Melatonin: How Melatonin Can Help Sleep and Bio Time, 2018. Available from: https://www.thesleepdoctor.com/2017/06/06/understanding-melatonin-melatonin-can-help-sleep-bio-time/ (Last accessed 27 Nov 2018).

Grima NA, Rajaratnam SMW, Mansfield D, Sletten TL, Spitz G, Ponsford JL. Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial. BMC Med. 2018; 16(1):8. https://doi.org/10.1186/s12916-017-0995-1 PMid:29347988 PMCid:PMC5774131

Alzoubi, KH, Mayyas FA, Khabour OF, Bani Salama FM, Alhashimi FH, Mhaidat NM. Chronic Melatonin Treatment Prevents Memory Impairment Induced by Chronic Sleep Deprivation. Molecular Neurobiology. 2016; 53(5):3439-3447. https://doi.org/10.1007/s12035-015-9286-z PMid:26084441

Sochan J. Top 2 sleep promoting nutritients: Magnesium and Calcium, 2018. Available from: https://www.naturimedica.com/top-2-sleep-promoting-nutrients-magnesium-and-calcium/ (Last accessed 27 Nov 2018).

Abbasi B, Kimiagar M, Sadeqhniiat K, Shirazi MM, Hedavati M, Rashidkhani B. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res med Sci. 2012; 17(12):1161-9.

Cao Y, Zhen S, Taylor AW, Appleton S, Atlantis E, Shi Z. Magnesium Intake and Sleep Disorder Symptoms: Findings from the Jiangsu Nutrition Study of Chinese Adults at Five-Year Follow-Up. Nutritients. 2018; 21(10):E1354. https://doi.org/10.3390/nu10101354 PMid:30248967 PMCid:PMC6212970

Boyle NB, Lawton C, Dye L. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress-A Systematic Review. Nutrients. 2017; 9(5):429. https://doi.org/10.3390/nu9050429 PMid:28445426 PMCid:PMC5452159

Tarleton EK, Littenberg B, Maclean CD, Kennedy AG, Daley C. Role of magnesium supplementation in the treatment of depression: A randomized clinical trial. PLoS One. 2017; 12(6):e0180067. https://doi.org/10.1371/journal.pone.0180067 PMid:28654669 PMCid:PMC5487054

Li L, Wu C, Gan Y, Qu X, Lu Z. Insomnia and the risk of depression: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2016; 16:375. https://doi.org/10.1186/s12888-016-1075-3 PMid:27816065 PMCid:PMC5097837

Comai S, Gobbi G. CCNP Award Paper: Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology. J Psychiatry Neurosci. 2014; 39(1):6-21. https://doi.org/10.1503/jpn.130009 PMid:23971978 PMCid:PMC3868666

Garfinkel D, Zisapel N, Wainstein J, et al. Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach. Arch Intern Med. 1999; 159:2456-60. https://doi.org/10.1001/archinte.159.20.2456 PMid:10665894

Sumaya IC, Masana MI, Dubocovich ML. The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors. J Pineal Res. 2005; 39:170-7. https://doi.org/10.1111/j.1600-079X.2005.00233.x PMid:16098095

Hickie IB, Rogers NL. Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet. 2011; 378:621-31. https://doi.org/10.1016/S0140-6736(11)60095-0

Xiaopeng J, Grander MA, Liu J. The relationship between micronutrient status and sleep patterns: a systematic review. Public Health Nutr. 2017; 20(4):687-701. https://doi.org/10.1017/S1368980016002603 PMid:27702409 PMCid:PMC5675071

Lichstein KL, Payne KL, Soeffing JP, Durrence HH, Taylor DJ, Riedel BW, Bush AJ. Vitamins and sleep: An exploration study. Sleep Med. 2008; 9(1):27-32. https://doi.org/10.1016/j.sleep.2006.12.009 PMid:17825610 PMCid:PMC2174691

Syed EU, Wasay M, Awan S. Vitamin B12 Supplementation in Treating Major Depressive Disorder: A Randomized Controlled Trial. Open Neurol J. 2013; 7:44-48. https://doi.org/10.2174/1874205X01307010044 PMid:24339839 PMCid:PMC3856388

Williams AI, Cotter A, Sabina A, Girard C, Goodman J, Katz DL. The role of vitamin B6 as treatment for depression: a systematic review. Family Practice. 2005; 22(5):532-37. https://doi.org/10.1093/fampra/cmi040 PMid:15964874

Ochoa-Sanchez R, Rainer Q, Comai S, et al. Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam. Prog neuropsychopharmacol BiolPsychiatry. 2012; 39:318-25. https://doi.org/10.1016/j.pnpbp.2012.07.003 PMid:22789661

Rondanelli M, Opizzi A, Monteferrario F, Antoniella N, Manni R, Klersy C. The effect of melatonin, magnesium, and zinc on primary insomnia in long-term care facility residents in Italy: a double-blind, placebo-controlled clinical trial. J Am Geriatr Soc. 2011; 59:82-90. https://doi.org/10.1111/j.1532-5415.2010.03232.x PMid:21226679

Published
2019-08-30
How to Cite
1.
Djokic G, Vojvodic P, Korcok D, Agic A, Rankovic A, Djordjevic V, Vojvodic A, Vlaskovic-Jovicevic T, Peric-Hajzler Z, Vojvodic J, Matovic D, Sijan G, Wollina U, Tirant M, Nguyen VT, Fioranelli M, Lotti T. The Effects of Magnesium – Melatonin - Vit B Complex Supplementation in Treatment of Insomnia. Open Access Maced J Med Sci [Internet]. 2019Aug.30 [cited 2020Oct.23];7(18):3101-5. Available from: https://www.id-press.eu/mjms/article/view/oamjms.2019.771

Most read articles by the same author(s)

1 2 3 > >>